The risk of vancomycin toxicity in patients with liver impairment | Annals of Clinical Microbiology and Antimicrobials | Full Text

The risk of vancomycin toxicity in patients with liver impairment | Annals of Clinical Microbiology and Antimicrobials | Full Text

The risk of vancomycin toxicity in patients with liver impairment

The influence of liver disease on the pharmacokinetic profile, the risk of acute kidney injury, and excessive drug exposure in patients treated with vancomycin was examined.

Authors:Luigi Brunetti, Jong Hwa Song, David Suh, Heui Jae Kim, Yeon Hee Seong, Dae Song Lee, Seung-Mi Lee and Dong-Churl Suh

Citation:Annals of Clinical Microbiology and Antimicrobials 2020 19:13

Content type:Research

Published on: 31 March 2020

• ViewFull Text
 
• ViewPDF